Chinese biopharma companies lead when it comes to manufacturing scale, CDMO capacity, and raw materials, according to analyses from the Cure Innovation Index.
The 128,000-square-foot Andover, Massachusetts facility will serve as the company’s first U.S. manufacturing site, supporting development of its targeted alpha therapy pipeline.
Go beyond similarity in this webchat with a Thermo Fisher Scientific expert on how a p-value-based multivariate residual approach verifies pharmaceutical raw materials.
